Published on: 03 September 2018
The IFPMA Code of Practice is a living document and has been revised five times over recent decades, ensuring that practices in the biopharmaceutical industry are governed by ethical standards in line with societal expectations. The new IFPMA Code of Practice will come into effect on 1st January 2019.
This Q&A summarizes the key changes between the new IFPMA Code of Practice 2019 and its 2012 predecessor, and discusses certain implications of these revisions for our members.
